NTRA Gross Margin

The Gross Margin of Natera, Inc. (NTRA) is 64.75%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

NTRA Gross Margin - Historical Value

Date	Value
2025-12-31	64.75%
2024-12-31	60.30%
2023-12-31	45.52%
2022-12-31	44.37%
2021-12-31	49.10%
2020-12-31	47.93%
2019-12-31	41.95%
2018-12-31	35.55%
2017-12-31	33.40%
2016-12-31	36.19%

NTRA Gross Margin - Peers Comparison

Ticker	Name	Value
950160.KQ	Kolon TissueGene Inc	13.28%
EXEL	Exelixis Inc	96.39%
INSM	Insmed Incorporated	79.73%
SRRK	Scholar Rock Holding Corporation	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
BBIO	BridgeBio Pharma, Inc.	95.82%
PGEN	Precigen, Inc.	50.20%
MDGL	Madrigal Pharmaceuticals, Inc.	94.14%
XNCR	Xencor, Inc.	7775.20%
ZNTL	Zentalis Pharmaceuticals, Inc.	7775.20%
MYGN	Myriad Genetics, Inc.	69.93%
ORGO	Organogenesis Holdings Inc.	75.62%
PTCT	PTC Therapeutics, Inc.	97.28%
REGN	Regeneron Pharmaceuticals, Inc.	86.56%
TWST	Twist Bioscience Corporation	50.72%
ABBV	AbbVie Inc.	71.62%
MGNX	MacroGenics Inc	75.91%
MORF	Morphic Holding Inc	7775.20%
MRNA	Moderna, Inc.	70.32%
OPK	OPKO Health, Inc.	36.84%
VRTX	Vertex Pharmaceuticals Incorporated	86.24%
950200.KQ	Psomagen Inc	24.48%
ACAD	Acadia Pharmaceuticals Inc.	91.69%
AGIO	Agios Pharmaceuticals, Inc.	88.26%
ALLK	Allakos LLC	7775.20%
TVTX	Travere Therapeutics, Inc.	97.89%
AMRN	Amarin Corporation PLC	56.57%
BCRX	BioCryst Pharmaceuticals, Inc.	97.82%
EDIT	Editas Medicine, Inc.	7775.20%
SRNE	Sorrento Therapeutics Inc	46.82%
NBIX	Neurocrine Biosciences, Inc.	98.18%
VCEL	Vericel Corporation	74.42%
VIR	Vir Biotechnology, Inc.	99.96%
AMGN	Amgen Inc	70.78%
ARWR	Arrowhead Pharmaceuticals, Inc.	100.00%
CBPO	China Biologic Products Holdings Inc	65.68%
GILD	Gilead Sciences, Inc.	78.84%